Donald Clark III, MD, MPH; Lisandro D. Colantonio, MD, PhD; Yuan-I Min, PhD; et al.
free access
JAMA Cardiol. 2019;4(12):1194-1202. doi:10.1001/jamacardio.2019.3773
This study assesses the population-attributable risk of cardiovascular disease associated with hypertension among black adults in the United States.
Stephen Y. Wang, MPH; Andy S. L. Tan, MD, PhD, MPH, MBA; Brian Claggett, PhD; et al.
free access
has audio
JAMA Cardiol. 2019;4(12):1203-1212. doi:10.1001/jamacardio.2019.3788
This cohort study examines the association between change in household income and subsequent risk of cardiovascular disease.
-
Podcast:
Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease
-
Invited Commentary
The Influence of Social and Economic Factors on Heart Disease
Edward P. Havranek, MD
JAMA Cardiol
-
Podcast:
Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease
Subodh Verma, MD, PhD, FRCSC; Stephen C. Bain, MD; John B. Buse, MD; et al.
open access
JAMA Cardiol. 2019;4(12):1214-1220. doi:10.1001/jamacardio.2019.3080
This post hoc analysis of a randomized clinical trial evaluates the association between liraglutide and total occurrences of any major adverse cardiovascular events (MACE) and expanded MACE among patients with type 2 diabetes and high risk of cardiovascular events.
Jonathan H. Kim, MD, MSc; Casey Hollowed, MSc; Chang Liu, MPH; et al.
free access
JAMA Cardiol. 2019;4(12):1221-1229. doi:10.1001/jamacardio.2019.3909
This cohort study assesses collegiate US football players to quantify the emergence and progression of multiple independent factors associated with cardiovascular risk across serial years of football participation.
Yingxi Chen, MD, PhD; Neal D. Freedman, PhD; Paul S. Albert, PhD; et al.
open access
JAMA Cardiol. 2019;4(12):1230-1238. doi:10.1001/jamacardio.2019.3891
This descriptive study examines trends in premature mortality from cardiovascular disease from 2000 to 2015 in US individuals age 25 to 64 years.
Jin Choul Chai, PhD; Amy A. Deik, PhD; Simin Hua, MS; et al.
free access
JAMA Cardiol. 2019;4(12):1239-1249. doi:10.1001/jamacardio.2019.4025
This cohort study evaluates plasma lipidomic profiles and their associations with carotid artery atherosclerosis in individuals with HIV and individuals without HIV.
Devin K. Patel, MD; Meredith S. Duncan, MA; Ashish S. Shah, MD; et al.
free access
JAMA Cardiol. 2019;4(12):1250-1259. doi:10.1001/jamacardio.2019.4032
This cohort study of Medicare data characterizes cardiac rehabilitation enrollment after cardiac valve surgery and its association with outcomes, including hospitalizations and mortality, in a national cohort of patients.
-
Invited Commentary
Strengthening the Evidence for Cardiac Rehabilitation Benefits
Randal J. Thomas, MD, MS; LaPrincess C. Brewer, MD, MPH
JAMA Cardiol
Gregg W. Stone, MD; Takeshi Kimura, MD; Runlin Gao, MD; et al.
free access
JAMA Cardiol. 2019;4(12):1261-1269. doi:10.1001/jamacardio.2019.4101
This individual patient data pooled analysis and meta-analysis examines the outcomes of first-generation bioresorbable vascular scaffolds in patients with coronary artery disease before and after 3 years.
Ersin Cavus, MD; Mahir Karakas, MD; Francisco M. Ojeda, PhD; et al.
free access
JAMA Cardiol. 2019;4(12):1270-1279. doi:10.1001/jamacardio.2019.4130
This population-based case-cohort study combines data from 7 European databases to investigate the association of circulating metabolites in serum samples with coronary heart disease onset.